Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Corda

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 23, 2022
ANMCO position paper: 2022 focused update of appropriate use criteria for multimodality imaging: aortic valve diseaseFederico Nardi, Paolo Giuseppe Pino, Leonardo De Luca, et al.
Transplantation|September 21, 2017
Optimizing the Safety Profile of Everolimus by Delayed Initiation in De Novo Heart Transplant Recipients: Results of the Prospective Randomized Study EVERHEARTLuciano Potena, Carlo Pellegrini, Francesco Grigioni, et al.
Circulation. Heart Failure|October 9, 2015
Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic CardiomyopathyDaniele Pasqualucci, Alessandra Fornaro, Gabriele Castelli, et al.
Giornale Italiano Di Cardiologia (2006)|April 27, 2023
[ANMCO Position paper: Wearable cardioverter defibrillator appropriate use guidance for the management of patients at high transient risk of sudden cardiac death]Giancarlo Casolo, Michele Massimo Gulizia, Daniela Aschieri, et al.
Giornale Italiano Di Cardiologia (2006)|November 26, 2024
[ANMCO Statement: semaglutide in cardio-nephro-metabolic disorders]Leonardo De Luca, Claudio Bilato, Alessandro Navazio, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 16, 2017
Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertensionRoberto Badagliacca, Amresh Raina, Stefano Ghio, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 22, 2023
ANMCO position paper: guide to the appropriate use of the wearable cardioverter defibrillator in clinical practice for patients at high transient risk of sudden cardiac deathGiancarlo Casolo, Michele Massimo Gulizia, Daniela Aschieri, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 19, 2025
ANMCO statement: semaglutide in the cardio-nephro-metabolic continuumLeonardo De Luca, Claudio Bilato, Alessandro Navazio, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|August 30, 2021
ANMCO POSITION PAPER: Prognostic and therapeutic relevance of non-obstructive coronary atherosclerosisGiancarlo Casolo, Domenico Gabrielli, Furio Colivicchi, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 24, 2024
ANMCO/SIMEU consensus document on the use of reversal agents for antithrombotic therapies in patients with ongoing bleeding or at high risk of haemorrhagic eventsLeonardo De Luca, Francesco Rocco Pugliese, Beniamino Susi, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 23, 2022
ANMCO position paper: 2022 focused update of appropriate use criteria for multimodality imaging: aortic valve diseaseFederico Nardi, Paolo Giuseppe Pino, Leonardo De Luca, et al.
Transplantation|September 21, 2017
Optimizing the Safety Profile of Everolimus by Delayed Initiation in De Novo Heart Transplant Recipients: Results of the Prospective Randomized Study EVERHEARTLuciano Potena, Carlo Pellegrini, Francesco Grigioni, et al.
Circulation. Heart Failure|October 9, 2015
Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic CardiomyopathyDaniele Pasqualucci, Alessandra Fornaro, Gabriele Castelli, et al.
Giornale Italiano Di Cardiologia (2006)|April 27, 2023
[ANMCO Position paper: Wearable cardioverter defibrillator appropriate use guidance for the management of patients at high transient risk of sudden cardiac death]Giancarlo Casolo, Michele Massimo Gulizia, Daniela Aschieri, et al.
Giornale Italiano Di Cardiologia (2006)|November 26, 2024
[ANMCO Statement: semaglutide in cardio-nephro-metabolic disorders]Leonardo De Luca, Claudio Bilato, Alessandro Navazio, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 16, 2017
Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertensionRoberto Badagliacca, Amresh Raina, Stefano Ghio, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 22, 2023
ANMCO position paper: guide to the appropriate use of the wearable cardioverter defibrillator in clinical practice for patients at high transient risk of sudden cardiac deathGiancarlo Casolo, Michele Massimo Gulizia, Daniela Aschieri, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 19, 2025
ANMCO statement: semaglutide in the cardio-nephro-metabolic continuumLeonardo De Luca, Claudio Bilato, Alessandro Navazio, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|August 30, 2021
ANMCO POSITION PAPER: Prognostic and therapeutic relevance of non-obstructive coronary atherosclerosisGiancarlo Casolo, Domenico Gabrielli, Furio Colivicchi, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 24, 2024
ANMCO/SIMEU consensus document on the use of reversal agents for antithrombotic therapies in patients with ongoing bleeding or at high risk of haemorrhagic eventsLeonardo De Luca, Francesco Rocco Pugliese, Beniamino Susi, et al.
Pageof 8